NL-OMON48806招募中不适用
PROFIT: PRospective studie OF Immune Tolerance induction (ITI) - PROFIT
niversitair Medisch Centrum Utrecht0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •1. Diagnosis of severe haemophilia A OR haemophilia B. ;AND
- •2A) Previously Untreated Patient (PUP, < 5 exposure days (EDs))
- •2B) Treatment with ITI due to presence of inhibitor, whereby ITI is defined as the administration of factor VIII or factor IX concentrate according to the local protocol with the aim of inducing tolerance ;AND
- •3. Willing and be able to understand the study information and sign the informed consent form. In case of minor patients, this will be done by a proxy.
排除标准
- •- Documented auto-immune disease
研究者
相似试验
招募中
2 期
Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N2 only) non-squamous Non-Small Cell Lung Cancer (NSCLC) to neoadjuvant ATEZOLIZUMAB plus Carboplatin/Nab PaclitaxelLung cancer2024-516590-75-00Universitaetsklinikum Heidelberg AöR, Universitaetsklinikum Heidelberg AöR20
招募中
不适用
Prospective study to evaluate trained immunity in kidney transplantationiertransplantatiegraft survivalkidney transplantationNL-OMON53183Radboud Universitair Medisch Centrum100
进行中（未招募）
1 期
Evaluation of safety following Immune Tolerance Induction treatment with turoctocog alfa in patients with haemophilia A following inhibitor development in NN7170-4213 trialEUCTR2016-003821-40-GBovo Nordisk A/S1
进行中（未招募）
1 期
Evaluation of safety following Immune Tolerance Induction treatment with turoctocog alfa in patients with haemophilia A following inhibitor development in NN7170-4213 trialHaemophilia AMedDRA version: 20.0 Level: LLT Classification code 10018938 Term: Haemophilia A (Factor VIII) System Organ Class: 100000004850EUCTR2016-003821-40-DEovo Nordisk A/S6
进行中（未招募）
1 期
Evaluation of safety following Immune Tolerance Induction treatment with turoctocog alfa in patients with haemophilia A following inhibitor development in NN7170-4213 trialHaemophilia AMedDRA version: 19.1Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-003821-40-BGovo Nordisk A/S9